CN101497926B - 快速同步检测沙眼衣原体、细小脲原体和解脲脲原体的试剂盒 - Google Patents
快速同步检测沙眼衣原体、细小脲原体和解脲脲原体的试剂盒 Download PDFInfo
- Publication number
- CN101497926B CN101497926B CN2008102369890A CN200810236989A CN101497926B CN 101497926 B CN101497926 B CN 101497926B CN 2008102369890 A CN2008102369890 A CN 2008102369890A CN 200810236989 A CN200810236989 A CN 200810236989A CN 101497926 B CN101497926 B CN 101497926B
- Authority
- CN
- China
- Prior art keywords
- ureaplasma urealyticum
- gene
- urealyticum
- chlamydia trachomatis
- copy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000202921 Ureaplasma urealyticum Species 0.000 title claims abstract description 46
- 239000003153 chemical reaction reagent Substances 0.000 title abstract description 8
- 238000001514 detection method Methods 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 6
- 244000052769 pathogen Species 0.000 claims abstract description 5
- 108090000790 Enzymes Proteins 0.000 claims abstract 2
- 102000004190 Enzymes Human genes 0.000 claims abstract 2
- 238000012408 PCR amplification Methods 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims description 36
- 241000606153 Chlamydia trachomatis Species 0.000 claims description 34
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 34
- 239000004202 carbamide Substances 0.000 claims description 34
- 229940038705 chlamydia trachomatis Drugs 0.000 claims description 34
- 239000000523 sample Substances 0.000 claims description 30
- 239000007850 fluorescent dye Substances 0.000 claims description 25
- 238000012360 testing method Methods 0.000 claims description 25
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 239000012634 fragment Substances 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 238000010791 quenching Methods 0.000 claims description 7
- 230000000171 quenching effect Effects 0.000 claims description 7
- 238000009004 PCR Kit Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000000137 annealing Methods 0.000 claims description 4
- 101150035767 trp gene Proteins 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000012154 double-distilled water Substances 0.000 claims description 3
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 101150008224 ureE gene Proteins 0.000 claims description 2
- 101100296682 Arabidopsis thaliana PCR10 gene Proteins 0.000 claims 1
- 208000019802 Sexually transmitted disease Diseases 0.000 abstract description 11
- 230000001360 synchronised effect Effects 0.000 abstract description 9
- 239000013612 plasmid Substances 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 238000002965 ELISA Methods 0.000 abstract description 3
- 238000012136 culture method Methods 0.000 abstract description 3
- 238000002405 diagnostic procedure Methods 0.000 abstract description 3
- 230000004907 flux Effects 0.000 abstract 1
- 238000011002 quantification Methods 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 20
- 238000003753 real-time PCR Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 208000000143 urethritis Diseases 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 206010018612 Gonorrhoea Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 238000013207 serial dilution Methods 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 125000006853 reporter group Chemical group 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 241000935255 Ureaplasma parvum Species 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 206010008323 cervicitis Diseases 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 201000003511 ectopic pregnancy Diseases 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 206010061041 Chlamydial infection Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 208000007893 Salpingitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 208000020426 gonococcal urethritis Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012913 prioritisation Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102369890A CN101497926B (zh) | 2008-12-23 | 2008-12-23 | 快速同步检测沙眼衣原体、细小脲原体和解脲脲原体的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102369890A CN101497926B (zh) | 2008-12-23 | 2008-12-23 | 快速同步检测沙眼衣原体、细小脲原体和解脲脲原体的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101497926A CN101497926A (zh) | 2009-08-05 |
CN101497926B true CN101497926B (zh) | 2012-02-29 |
Family
ID=40945197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102369890A Active CN101497926B (zh) | 2008-12-23 | 2008-12-23 | 快速同步检测沙眼衣原体、细小脲原体和解脲脲原体的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101497926B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102277429B (zh) * | 2011-07-22 | 2013-01-09 | 广东凯普生物科技股份有限公司 | 淋球菌、沙眼衣原体及解脲脲原体检测试剂盒 |
CN103184272A (zh) * | 2011-12-27 | 2013-07-03 | 上海复星医学科技发展有限公司 | 沙眼衣原体、解脲脲原体、细小脲原体和淋球菌的检测试剂盒 |
CN103882133A (zh) * | 2014-03-31 | 2014-06-25 | 深圳意达凯生物科技有限公司 | 一种用于检测解脲脲原体的引物对、试剂盒及其应用 |
CN108660226A (zh) * | 2017-03-28 | 2018-10-16 | 宣捷干细胞生技股份有限公司 | 用于检测微小脲原体血清型3的引物对及其试剂盒 |
CN110656189B (zh) * | 2019-10-30 | 2023-08-11 | 郑州安图生物工程股份有限公司 | 一种单管多重快速检测沙眼衣原体、淋球菌及解脲脲原体的荧光pcr试剂盒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1170042A (zh) * | 1996-07-05 | 1998-01-14 | 中国科学院动物研究所 | 沙眼衣原体,解脲脲原体,淋病奈瑟菌的单管同步三重pcr检测方法 |
CN1873023A (zh) * | 2006-04-14 | 2006-12-06 | 武汉大学 | 快速检测沙眼衣原体的荧光定量pcr试剂盒 |
CN1873024A (zh) * | 2006-04-14 | 2006-12-06 | 武汉大学 | 快速检测细小脲原体的荧光定量pcr试剂盒 |
CN100363504C (zh) * | 2006-04-14 | 2008-01-23 | 武汉大学 | 同步检测沙眼衣原体和细小脲原体的荧光定量pcr试剂盒 |
-
2008
- 2008-12-23 CN CN2008102369890A patent/CN101497926B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1170042A (zh) * | 1996-07-05 | 1998-01-14 | 中国科学院动物研究所 | 沙眼衣原体,解脲脲原体,淋病奈瑟菌的单管同步三重pcr检测方法 |
CN1873023A (zh) * | 2006-04-14 | 2006-12-06 | 武汉大学 | 快速检测沙眼衣原体的荧光定量pcr试剂盒 |
CN1873024A (zh) * | 2006-04-14 | 2006-12-06 | 武汉大学 | 快速检测细小脲原体的荧光定量pcr试剂盒 |
CN100363504C (zh) * | 2006-04-14 | 2008-01-23 | 武汉大学 | 同步检测沙眼衣原体和细小脲原体的荧光定量pcr试剂盒 |
Non-Patent Citations (3)
Title |
---|
XiaoTian Zheng et al.Small Repeating Units within the Ureaplasma urealyticum MB Antigen Gene Encode Serovar Specificity and Are Associated with Antigen Size Variation.《Infection and Immunity》.1995,第63卷(第3期),891-898. * |
张彦丽.解脲脲原体MB抗原保守区段的表达与抗体制备及初步应用.《中国优秀硕士学位论文全文数据库(电子期刊)》.2006,E059-176. * |
邹冬冬.利用解脲脲原体MBA基因对解脲脲原体分型并比较分析其临床意义.《中国优秀硕士学位论文全文数据库(电子期刊)》.2007,E068-1. * |
Also Published As
Publication number | Publication date |
---|---|
CN101497926A (zh) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110982943B (zh) | 一种新型冠状病毒rt-pcr检测方法及试剂盒 | |
CN100352943C (zh) | 快速检测沙眼衣原体的荧光定量pcr试剂盒 | |
CN105624330B (zh) | 同时检测12种猪常见病毒及细菌Taqman-MGB荧光定量PCR试剂盒及方法 | |
CN106957927B (zh) | 非洲猪瘟荧光pcr检测试剂、非洲猪瘟荧光pcr检测试剂盒及其应用 | |
CN101979666B (zh) | 快速检测单纯疱疹病毒ⅱ型的荧光定量pcr试剂盒 | |
CN106811550B (zh) | 一种草鱼呼肠孤病毒ⅱ型疫苗株和野毒株鉴别引物及含有其的试剂盒与诊断检测方法 | |
CN105420379A (zh) | 牛支原体的实时荧光定量PCR检测试剂盒及其专用引物、TaqMan探针 | |
CN105624329B (zh) | 单纯疱疹病毒1型实时荧光核酸恒温扩增检测试剂盒 | |
CN101979667B (zh) | 同步检测单纯疱疹病毒i型和ⅱ型的荧光定量pcr试剂盒 | |
CN106048094B (zh) | 猪伪狂犬病野毒株与基因缺失株的双重实时荧光定量pcr检测试剂盒及引物和探针 | |
CN101497926B (zh) | 快速同步检测沙眼衣原体、细小脲原体和解脲脲原体的试剂盒 | |
CN102102121A (zh) | 检测解脲支原体的荧光pcr试剂盒 | |
CN100352944C (zh) | 快速检测细小脲原体的荧光定量pcr试剂盒 | |
CN101979668B (zh) | 快速检测单纯疱疹病毒i型的荧光定量pcr试剂盒 | |
Li et al. | Development of a recombinase-aided amplification combined with lateral flow dipstick assay for the rapid detection of the African swine fever virus | |
CN102108405A (zh) | 快速检测淋球菌的荧光定量pcr试剂盒 | |
Tang et al. | Novel multiplex real-time PCR system using the SNP technology for the simultaneous diagnosis of Chlamydia trachomatis, Ureaplasma parvum and Ureaplasma urealyticum and genetic typing of serovars of C. trachomatis and U. parvum in NGU | |
CN103740864A (zh) | 一种高致病性猪蓝耳病毒荧光定量qRT-PCR检测方法及检测试剂盒 | |
CN101705310A (zh) | 猪星状病毒的荧光定量pcr检测方法 | |
CN100363504C (zh) | 同步检测沙眼衣原体和细小脲原体的荧光定量pcr试剂盒 | |
CN113186321A (zh) | 一种芽囊原虫绝对荧光定量pcr检测方法 | |
CN101392299B (zh) | 一种马流感检测试剂盒和检测方法 | |
CN101613752A (zh) | 快速检测杜氏利什曼原虫的荧光定量pcr试剂盒 | |
Yin et al. | Visual detection and differentiation of porcine epidemic diarrhea virus wild− type strains and attenuated vaccine strains using CRISPR/Cas13a-based lateral flow strip | |
CN102108423A (zh) | 快速检测16、18型人乳头瘤病毒的荧光定量pcr试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WANG YEFU Free format text: FORMER OWNER: WUHAN UNIVERSITY Effective date: 20130220 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130220 Address after: 430072, No. 4, No. 4, East Central District, Wuhan University, Wuchang District, Hubei, Wuhan, 602 Patentee after: Wang Yefu Address before: 430072 Hubei city of Wuhan province Wuchang Luojiashan Patentee before: Wuhan University |
|
ASS | Succession or assignment of patent right |
Owner name: WUHAN ZHENFU PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WANG YEFU Effective date: 20140320 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140320 Address after: 430072 No. 166, hi tech Avenue, East Lake Development Zone, Hubei, Wuhan Patentee after: WUHAN ZHENFU PHARMACEUTICAL Co.,Ltd. Address before: 430072, No. 4, No. 4, East Central District, Wuhan University, Wuchang District, Hubei, Wuhan, 602 Patentee before: Wang Yefu |
|
TR01 | Transfer of patent right |
Effective date of registration: 20231227 Address after: Buildings 1, 2, and 4, Phase I of Donghu High tech Smart City, No. 216 Jianshe Avenue, Gedian Development Zone, Ezhou City, Hubei Province, 436070 Patentee after: Hubei Zhen Fu Pharmaceutical Co.,Ltd. Address before: No. 166, Gaoxin Avenue, Donghu Development Zone, Wuhan City, Hubei Province, 430072 Patentee before: WUHAN ZHENFU PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |